Equities

Sharda Cropchem Ltd

SHARDACROP:NSI

Sharda Cropchem Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)357.40
  • Today's Change-1.05 / -0.29%
  • Shares traded60.14k
  • 1 Year change-21.97%
  • Beta1.3125
Data delayed at least 15 minutes, as of Apr 19 2024 11:22 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sharda Cropchem Limited is an India-based agrochemicals company. The Company is focused on agrochemicals and non-agrichemical businesses. The Company operates through an asset-light business model, and its core competency lies in developing product dossiers and obtaining product registrations in different countries. The Company operates through two segments: Agrochemicals and Non-agrochemicals. Agrochemicals segment is engaged in Insecticides, Herbicides, Fungicides and Biocides. Non-agrochemicals segment is engaged in Conveyor Belts, V Belts and Timing Belts. Its product portfolio in the agrochemical business comprises formulations and generic active ingredients in fungicide, herbicide and insecticide segments for protecting different kinds of crops, as well as serving turf and specialty markets and a range of formulations and generic active ingredients. The product portfolio in the non-agrochemical business comprises belts, general chemicals, dyes and dye intermediates.

  • Revenue in INR (TTM)33.33bn
  • Net income in INR872.52m
  • Incorporated2004
  • Employees182.00
  • Location
    Sharda Cropchem LtdDomnic Holm, 29th Road, Bandra (West)MUMBAI 400056IndiaIND
  • Phone+91 2 266782800
  • Fax+91 2 266782828
  • Websitehttp://shardacropchem.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Premier Explosives Limited2.37bn240.15m21.72bn822.0090.50--61.899.1522.3222.32220.46--------2,886,219.00--0.159--0.229262.0347.0210.140.2542--3.67----1.46-6.3430.32-3.25-1.93-7.42
Gocl Corporation Ltd7.69bn570.72m21.76bn222.0038.11--31.562.8311.5211.52155.23--------34,656,330.00--4.51--5.3123.0127.617.4219.41---0.1333--17.8384.8413.1419.9144.00-1.0625.59
Yasho Industries Ltd5.73bn556.75m21.90bn659.0039.23--30.393.8248.9648.96504.09--------8,698,619.00--9.43--18.5136.0632.219.717.26--5.54--0.67359.6121.8729.8053.4755.03--
IOL Chemicals and Pharmaceuticals Ltd.22.16bn1.72bn22.84bn2.56k13.32--9.921.0329.2229.22377.38--------8,666,719.00--18.93--25.0734.4735.177.7413.56--12.39--7.621.5217.24-17.0238.1034.37--
Astec LifeSciences Limited4.31bn-509.39m24.74bn551.00------5.73-25.98-25.98220.09--------7,829,481.00--7.99--17.1330.4130.42-11.809.38---1.93--5.57-7.1511.12-71.55-6.0418.730.00
India Glycols Ltd74.98bn1.71bn25.74bn1.28k15.04--9.360.343355.2655.262,421.80--------58,398,440.00--3.79--6.6610.5610.732.282.71--2.85--12.440.60959.80-62.055.3227.6413.40
India Pesticides Ltd7.52bn891.33m26.61bn280.0029.75--25.773.547.777.7765.60--------26,866,790.00--------41.48--11.85----24.73----23.57---9.32------
Thirumalai Chemicals Ltd19.88bn-311.60m28.11bn526.00----89.301.41-3.04-3.04194.33--------37,785,930.00--8.76--12.1521.7128.27-1.578.27---0.4122--16.706.719.78-68.06-12.0243.84-5.59
Tatva Chintan Pharma Chem Ltd4.20bn376.99m28.68bn608.0072.74--48.116.8316.8516.85185.84--------6,903,800.00--------50.52--8.98----4.93-----2.31---52.56------
Sharda Cropchem Ltd33.33bn872.52m32.34bn182.0037.01--8.790.97039.689.68368.78--------183,120,800.00--8.73--14.9325.0528.692.628.99------11.4413.0018.84-2.0912.383.888.45
Neogen Chemicals Ltd6.95bn330.50m36.07bn581.00103.21--66.375.1913.2513.25276.25--------11,961,270.00--7.00--10.9543.5030.034.768.55--2.06--14.9540.8333.1411.9736.6249.51--
Bharat Rasayan Ltd10.41bn586.50m39.48bn797.0067.31--46.703.79141.16141.162,505.13--------13,060,150.00--17.10--22.8828.4728.495.6312.57--28.84--0.4305-5.138.78-29.194.85-10.500.00
Rossari Biotech Ltd17.64bn1.26bn40.59bn500.0032.40--21.842.3022.6822.68318.70--------35,286,180.00--11.98--16.6329.6330.447.127.98--9.04--2.0311.6640.829.8133.3918.75--
Fineotex Chemical Ltd5.54bn1.16bn41.22bn103.0035.66--33.827.4410.4410.4450.02--------53,751,720.00--17.65--21.9038.3335.2121.0515.49--136.92--8.2540.4029.3260.0731.2346.9631.95
Data as of Apr 19 2024. Currency figures normalised to Sharda Cropchem Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

13.19%Per cent of shares held by top holders
HolderShares% Held
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Mar 20247.38m8.19%
DSP Asset Managers Pvt. Ltd.as of 31 Mar 20243.61m4.00%
Dimensional Fund Advisors LPas of 04 Apr 2024493.71k0.55%
Mellon Investments Corp.as of 04 Apr 202488.02k0.10%
BlackRock Advisors (UK) Ltd.as of 02 Apr 202478.24k0.09%
SSgA Funds Management, Inc.as of 04 Apr 202472.28k0.08%
BlackRock Fund Advisorsas of 04 Apr 202466.10k0.07%
IDBI Asset Management Ltd.as of 31 Mar 202438.49k0.04%
TIAA-CREF Investment Management LLCas of 29 Feb 202435.78k0.04%
Acadian Asset Management LLCas of 30 Sep 202333.30k0.04%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.